Seer, Inc. cash flow statement
In fiscal 2025, Seer, Inc.'s operations generated −$44.4m of cash; it spent $1.8m on capital projects, leaving free cash flow of −$46.2m.
Cash flow statement
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | −21 | −46 | −61 | −59 | −46 | −44 | −43 |
| Depreciation and amortisation | 2 | 3 | 4 | 5 | 6 | 5 | 5 |
| Stock-based pay | 7 | 26 | 34 | 34 | 28 | 15 | 11 |
| Capital spending | 5 | 7 | 10 | 7 | 4 | 2 | 1 |
| Free cash flow | −25 | −53 | −71 | −66 | −50 | −46 | −44 |
| Free cash flow after stock pay | −33 | −79 | −105 | −101 | −78 | −62 | −55 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | — | — |
| Shares issued | 0 | 103 | 0 | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −14 | −11 | −11 | −15 | −8 | −11 | −15 | −10 |
| Depreciation and amortisation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Stock-based pay | 7 | 6 | 5 | 4 | 4 | 3 | 2 | 2 |
| Capital spending | 2 | −1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Free cash flow | −16 | −11 | −12 | −15 | −8 | −11 | −16 | −10 |
| Free cash flow after stock pay | −23 | −17 | −17 | −19 | −11 | −14 | −18 | −11 |
Compare with peers
- Bionano Genomics, Inc. cash flow
- Maxcyte, Inc. cash flow
- Rapid Micro Biosystems, Inc. cash flow
- Omniab, Inc. cash flow
- Alpha Teknova, Inc. cash flow
Head to head: BNGO vs SEERMXCT vs SEERRPID vs SEER
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies